Emcure Pharmaceuticals Limited has informed the Exchange about Schedule of meet
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals has informed the stock exchanges about its upcoming schedule of analyst and investor meetings. The meetings are planned for Monday, June 23, 2025, and Tuesday, June 24, 2025, and have been organized by Kotak Investment Banking. The format will be physical one-to-one meetings held in Mumbai. The company clarified that no unpublished price sensitive information (UPSI) will be shared or discussed during these meetings. The schedule is described as tentative and may change due to unforeseen circumstances. The disclosure has been made under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulation 30.
This is a routine regulatory disclosure with no direct material impact on the stock price. Investors may read it as a sign of ongoing engagement with institutional investors, but no new business information is being shared at this stage.